These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 27139420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer.
    Duan J, Sun L, Huang H, Wu Z, Wang L, Liao W.
    Mol Med Rep; 2016 Apr; 13(4):3027-35. PubMed ID: 26936091
    [Abstract] [Full Text] [Related]

  • 8. AZGP1 suppresses the process of colorectal cancer after upregulating FASN expression via mTOR signal pathway.
    Yu W, Ling J, Yu H, Du J, Liu T.
    Gen Physiol Biophys; 2020 May; 39(3):239-248. PubMed ID: 32525817
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.
    Zaytseva YY, Harris JW, Mitov MI, Kim JT, Butterfield DA, Lee EY, Weiss HL, Gao T, Evers BM.
    Oncotarget; 2015 Aug 07; 6(22):18891-904. PubMed ID: 25970773
    [Abstract] [Full Text] [Related]

  • 10. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
    Chang L, Wu P, Senthilkumar R, Tian X, Liu H, Shen X, Tao Z, Huang P.
    J Cancer Res Clin Oncol; 2016 Jan 07; 142(1):59-72. PubMed ID: 26109148
    [Abstract] [Full Text] [Related]

  • 11. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.
    Ye M, Hu C, Chen T, Yu P, Chen J, Lu F, Xu L, Zhong Y, Yan L, Kan J, Bai J, Li X, Tian Y, Tang Q.
    Int J Biol Sci; 2023 Jan 07; 19(10):3115-3127. PubMed ID: 37416772
    [Abstract] [Full Text] [Related]

  • 12. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
    Lu F, Ye M, Hu C, Chen J, Yan L, Gu D, Xu L, Tian Y, Bai J, Tang Q.
    Cancer Sci; 2023 Sep 07; 114(9):3553-3567. PubMed ID: 37302809
    [Abstract] [Full Text] [Related]

  • 13. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X, Liao W, Zhang L, Tu X, Hu J, Chen T, Dai X, Xiong Y, Liang W, Ding C, Liu R, Dai J, Wang O, Lu L, Lu X.
    Cancer Lett; 2017 Aug 28; 402():153-165. PubMed ID: 28600110
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ZNF281 Regulates Cell Proliferation, Migration and Invasion in Colorectal Cancer through Wnt/β-Catenin Signaling.
    Qin CJ, Bu PL, Zhang Q, Chen JT, Li QY, Liu JT, Dong HC, Ren XQ.
    Cell Physiol Biochem; 2019 Aug 28; 52(6):1503-1516. PubMed ID: 31112017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.